The FDA has even approved a drug manufactured with cannabidiol for that reason (Epidiolex). Although the company only recommends it for two uncommon types of childhood epilepsy referred to as Lennox-Gastaut syndrome and Dravet syndrome.In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify cannabis like a Schedule